Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
UNITED THERAPEUTICS Corp market cap for the quarter ending 2026-07-29 was $22.51B, a 62.88% increase year-over-year.
UNITED THERAPEUTICS Corp market cap for the quarter ending 2026-06-30 was $23.13B, a 77.87% increase year-over-year.
UNITED THERAPEUTICS Corp market cap for the quarter ending 2026-04-29 was $24.24B, a 83.09% increase year-over-year.
UNITED THERAPEUTICS Corp market cap for the quarter ending 2026-03-31 was $25B, a 79.91% increase year-over-year.
UNITED THERAPEUTICS Corp market cap for fiscal 2026 was $22.51B.
UNITED THERAPEUTICS Corp market cap for fiscal 2025 was $21.25B, a 34.35% increase from fiscal 2024.
UNITED THERAPEUTICS Corp market cap for fiscal 2024 was $15.82B, a 52.93% increase from fiscal 2023.
UNITED THERAPEUTICS Corp market cap for fiscal 2023 was $10.34B, a 19.20% decline from fiscal 2022.